Back to Search

TAREK MANSOUR, MD

MD

Student in an Organized Health Care Education/Training Program

NPI: 1164041240Individual

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training ProgramPrimary

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Research & Publications (20)

Naphthyl tetronic acids as multi-target inhibitors of bacterial peptidoglycan biosynthesis.
PMID 17600795·ChemMedChem·2007
8-other
On the absolute configuration in 1,4-dihydrothiazepine covalent complexes derived from inhibition of class A and C beta-lactamases with 6-methylidene penems.
PMID 17868160·ChemMedChem·2007
8-other
Simultaneous hydrogenolysis of p-nitrobenzyl esters and carbamates side-chains in the THF 1beta-carbapenem OCA-983 in biphasic media.
PMID 16787352·Med Chem·2006
8-other
2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
PMID 19640711·Bioorg Med Chem Lett·2009
7-preclinical
Oxidative palladium catalysis in S(N)Ar reactions leading to heteroaryl ethers from pyridotriazol-1-yloxy heterocycles with aryl boronic acids.
PMID 19265423·J Am Chem Soc·2009
8-other
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.
PMID 19584280·Cancer Res·2009
7-preclinical
Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine.
PMID 19309081·J Med Chem·2009
8-other
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
PMID 19317452·J Med Chem·2009
7-preclinical
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines.
PMID 19645448·J Med Chem·2009
7-preclinical
A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).
PMID 19278250·J Med Chem·2009
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
450 CLARKSON AVE
BROOKLYN, NY 11203

Quick Facts

NPI
1164041240
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile